Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fixed combination drug therapy

G M Shenfield

    Drugs
    |June 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Fixed combination drugs offer benefits like improved compliance but pose risks such as inflexible dosing. Careful consideration of necessity and risk-benefit is crucial for their appropriate use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The effect of different nebulizers with and without intermittent positive pressure breathing on the absorption and metabolism of salbutamol.

    British journal of clinical pharmacology·2012
    Same author

    The clinical pharmacology of salmefamol.

    British journal of clinical pharmacology·2012
    Same author

    The effect of prednisone treatment on the half-life of intravenous hydrocortisone.

    British journal of clinical pharmacology·2012
    Same author

    Absorption of drugs by the lung.

    British journal of clinical pharmacology·2012
    Same author

    Failure to weigh patients in hospital: a medication safety risk.

    Internal medicine journal·2007
    Same author

    The many essential interfaces of clinical pharmacology.

    Clinical and experimental pharmacology & physiology·2001
    Same journal

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    Drugs·2026
    Same journal

    Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

    Drugs·2026
    Same journal

    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

    Drugs·2026
    Same journal

    Relacorilant: First Approval.

    Drugs·2026
    Same journal

    Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

    Drugs·2026
    Same journal

    Linerixibat: First Approval.

    Drugs·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Drug Development
    • Clinical Pharmacy

    Background:

    • Fixed combination preparations constitute a significant portion of marketed drugs.
    • Despite their prevalence, scientific investigation into these preparations remains limited.
    • Existing discourse is characterized by strong opinions rather than empirical evidence.

    Purpose of the Study:

    • To critically evaluate the advantages and disadvantages of fixed combination drug preparations.
    • To assess the scientific basis and clinical utility of these drug formulations.
    • To provide guidance on appropriate prescribing practices for combination therapies.

    Main Methods:

    • Literature review and critical analysis of existing studies on fixed combination drugs.
    • Examination of potential benefits including compliance, synergy, efficacy, and cost-effectiveness.

    Related Experiment Videos

  • Identification of potential drawbacks such as fixed dose ratios, pharmacokinetic incompatibilities, toxicity, and knowledge gaps.
  • Main Results:

    • While some combinations (e.g., oral contraceptives, levodopa/decarboxylase inhibitors) have established value, many others are overprescribed.
    • Widespread use in over-the-counter products may lead to unrecognized adverse effects.
    • The necessity of each component and a favorable risk-benefit profile are key considerations.

    Conclusions:

    • Fixed combination drugs should only be used when each component is essential and benefits clearly outweigh risks.
    • Clinicians must question the need for each drug in a combination versus monotherapy.
    • Enhanced medical education on the pros and cons of fixed combinations is recommended to improve prescribing habits.